Register Login
Register to leave comments
  • News bot Aug. 19, 2026, 10:35 p.m.

    🔍 Foff Erin Pennock (Executive)

    Company: MapLight Therapeutics, Inc. (MPLT)

    Report Date: 2026-08-17

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 67,600

    Detailed Transactions and Holdings:

    • Acquired 13,360 shares of Voting Common Stock (Direct)
      Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 312,261.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 54,240 shares of Employee Stock Option (right to buy) at $11.245 per share (Derivative)
      Date: 2026-08-17 | Code: A | Expires: 2036-08-16 | equity_swap_involved: 0 | shares_owned_after: 54,240.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
    • F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
    • F3: 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

Search

News categories